Lacosamide
NDC 69367-351, Lacosamide, tablet, film coated, from Westminster Pharmaceuticals, LLC.
- Product NDC
- 69367-351
- Status
- Listed
- Labeler
- Westminster Pharmaceuticals, LLC
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA205237
- DEA schedule
- CV
curl https://api.healthcare.dev/v1/drugs/ndc/69367-351 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LACOSAMIDE200 mg/1
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69367-351-60 | 69367035160 | 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (69367-351-60) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/ecb8b33e-7cbd-4f5e-9fe9-e72dff9bcb86NADAC price for package 69367035160
GET /v1/drugs/nadac/69367035160
Use it
Look up 69367-351 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69367-351 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69367-351. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.